New technique: It involves iPS cells from hiv resistant people for the treatment of people infected with this virus
Some people have a mutation in their genome (CCR5A32) that gives them certain resistance to HIV infection. Taking advantage of this situation, a step has now been taken that could be useful for the treatment of HIV-positive individuals. It involves deriving iPS cells from these individuals and producing monocytes / macrophages from them. The authors demonstrated their resistance to HIV infection and suggested that this strategy could open a doorway for the treatment of individuals infected with this virus (PNAS 111; 9591-9596,2014).
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.